Drug –drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
ConclusionThe commonest co-medications leading to contraindication during DAA treatment were statins and antipsychotics. Category 2 and 3 DDIs are often managed by appropriate dose adjustments or temporary discontinuation of relevant co-medications. Careful assessment for potential DDI before DAA use is mandatory to avoid potential harmful effects.Graphical abstract
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Calcium | Cholesterol | Clinical Trials | Hepatitis | Hepatitis C | Infectious Diseases | Statin Therapy | Study